| Auro Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530233 |
NSE Symbol : - |
P/E(TTM) : 28.48 |
|
ISIN Demat : INE292C01011 |
Div & Yield% : - |
EPS(TTM) : 9.90 |
|
Book Value(₹) : 69.61 |
Market Cap(₹Cr) : 175.65 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 3.10 | 5.72 | 12.06 | 17.98 | 13.41 | 10.18 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3.10 | 5.72 | 12.06 | 17.98 | 13.41 | 10.18 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.31 | 0.20 | 0.40 | 0.42 | 0.32 | 0.36 |
| Total Income | 3.41 | 5.92 | 12.46 | 18.40 | 13.73 | 10.55 |
| Total Expenditure | 2.38 | 4.40 | 9.65 | 13.90 | 10.38 | 9.03 |
| PBIDT | 1.03 | 1.53 | 2.81 | 4.50 | 3.35 | 1.52 |
| Interest | 0.28 | 0.25 | -0.32 | 0.44 | 0.35 | 0.27 |
| PBDT | 0.75 | 1.28 | 3.13 | 4.06 | 3.00 | 1.25 |
| Depreciation | 0.27 | 0.27 | 0.28 | 0.27 | 0.27 | 0.27 |
| Tax | 0.12 | 0.25 | 0.72 | 1.05 | 0.76 | 0.27 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -0.19 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.36 | 0.75 | 2.32 | 2.73 | 1.97 | 0.71 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.36 | 0.75 | 2.32 | 2.73 | 1.97 | 0.71 |
| EPS (Unit Curr.) | 0.57 | 1.21 | 3.72 | 4.39 | 3.16 | 1.14 |
| EPS (Adj) (Unit Curr.) | 0.57 | 1.21 | 3.72 | 4.39 | 3.16 | 1.14 |
| Calculated EPS (Unit Curr.) | 0.57 | 1.21 | 3.72 | 4.39 | 3.16 | 1.14 |
| Calculated EPS (Adj) (Unit Curr.) | 0.57 | 1.21 | 3.72 | 4.39 | 3.16 | 1.14 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.30 | 4.83 | 14.89 | 17.55 | 12.63 | 4.54 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.30 | 4.83 | 14.89 | 17.55 | 12.63 | 4.54 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 33.23 | 26.75 | 23.30 | 25.03 | 24.98 | 14.93 |
| PBDTM(%) | 24.19 | 22.38 | 25.95 | 22.58 | 22.37 | 12.28 |
| PATM(%) | 11.61 | 13.11 | 19.24 | 15.18 | 14.69 | 6.97 |